Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine.

about

Update on radionuclide therapy in oncology.

P2860

Q47552162-C2BD584C-C545-471D-984B-E3BE0F8705C4

P2860

Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine.

Item

http://www.wikidata.org/entity/Q38847122

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Modeling therapeutic response ...... y for individualized medicine.

@en

type

Item

label

Modeling therapeutic response ...... y for individualized medicine.

@en

prefLabel

Modeling therapeutic response ...... y for individualized medicine.

@en

P1476

Modeling therapeutic response ...... y for individualized medicine.

@en

P2093

Antony Kelly

http://www.w3.org/2001/XMLSchema#string

Christophe Meille

http://www.w3.org/2001/XMLSchema#string

Claire Bournaud

http://www.w3.org/2001/XMLSchema#string

Claire Schvartz

http://www.w3.org/2001/XMLSchema#string

David Taïeb

http://www.w3.org/2001/XMLSchema#string

Dominique Barbolosi

http://www.w3.org/2001/XMLSchema#string

Ilyssa Summer

http://www.w3.org/2001/XMLSchema#string

Isabelle Keller

http://www.w3.org/2001/XMLSchema#string

Marie-Elisabeth Toubert

http://www.w3.org/2001/XMLSchema#string

Michel Toubeau

http://www.w3.org/2001/XMLSchema#string

P2860

Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging.

Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapy.

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

Deciphering death: a commentary on Gompertz (1825) 'On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies'.

A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol.

A quantitative model for the dynamics of serum prostate-specific antigen as a marker for cancerous growth: an explanation for a medical anomaly.

Dosimetry and thyroid cancer: the individual dosage of radioiodine.

Metronomics chemotherapy: time for computational decision support.

Computational oncology--mathematical modelling of drug regimens for precision medicine.

Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach.

P304

39167-39176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16637

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marie-Elisabeth Toubert

P577

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28389624

http://www.w3.org/2001/XMLSchema#string

P932

5503603

http://www.w3.org/2001/XMLSchema#string

Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine.

about

P2860

P2860

Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932